Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:32 PM
Ignite Modification Date:
2025-12-24 @ 9:32 PM
NCT ID:
NCT04510532
Eligibility Criteria:
Inclusion Criteria:
* Age between 18-70 years old.
* Invasive breast cancer confirmed by Pathology
* Left ventricular ejection fraction ≥ 50%
* Having not received any prior systemic anti-cancer therapy for advanced disease
* an Eastern Cooperative Oncology Group（ECOG） performance status 0-1
* Providing written informed consent
Inclusion Criteria for Control group:
* Absence of known systemic diseases
* Normal examinations
* Age between 18-70 years old.
* Providing written informed consent
Exclusion Criteria:
* Age \<18 years old or \>70 years old
* Documented coronary artery disease or prior angiography for coronary artery disease (\>50% stenosis).
* Patients with bilateral invasive breast cancers.
* Patients with metastasis of breast cancer confirmed by imaging or pathology
* Patients with standard metallic contraindications to CMR or an estimated glomerular filtration rate \< 30 ml/min/1.73 m2.
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT04510532
Study Brief:
Protocol Section:
NCT04510532